Mapping large numbers of results may take a few moments.
Search Results
Showing 301 - 350 of 489 results found.
Company | Activity | Company Description | Location | |
---|---|---|---|---|
Company Mucommune LLC | Activity: Research and Development | Company Description Mucommune is developing a platform using monoclonal antibodies and mucus to reinforce the mucus barrier for female reproductive health. | Location Durham | |
Company MultiSeq Inc. | Activity: Research and Development | Company Description MultiSeq out-licenses molecular diagnostics platform technologies for cancer and infectious disease diagnosis. | Location Greensboro | |
Company Mycologics | Activity: Research and Development | Company Description Mycologics develops green antimicrobials to safeguard food, feed, and health from harmful fungal pathogens and their toxins (mycotoxins). | Location Durham | |
Company Mycorrhiza Biotech LLC | Activity: Research and Development | Company Description Mycorrhiza Biotech develops products and services to improve plant production. They specialize in fungi and allied organisms for diverse applications in agri-business. | Location Burlington | |
Company Mycosynthetix Inc. | Activity: Research and Development | Company Description Mycosynthetix manages a large collection of fungal isolates and discovers novel fungal metabolites for human and animal health and compounds for agricultural applications. | Location Hillsborough | |
Company Mycovia Pharmaceuticals Inc. | Activity: Research and Development | Company Description Mycovia Pharmaceuticals is developing therapies to treat yeast and fungal infections. | Location Durham | |
Company Myodenovo | Activity: Research and Development | Company Description Myodenovo is developing cultivated meat products. | Location Durham | |
Company NabGen Inc. | Activity: Research and Development | Company Description NabGen has developed a universal antibody suppressant technology to inhibit anti-drug and autoimmune antibodies, including suppression of pre-existing immunity and re-administration barriers to gene therapies based on adeno-associated virus (AAV) vectors. | Location Durham | |
Company NanoDiagnostic Technology LLC | Activity: Research and Development | Company Description Nanodiagnostic Technology develops nanotechnology-based portable analytical devices for onsite rapid and sensitive detection of toxic chemical exposure, SARs-COV-2, and diseases at the point of care. | Location Kannapolis | |
Company Natures Crops International | Activity: Research and Development | Company Description Natures Crops supplies plant-derived ingredients from biodiverse and specialty crops to the dietary supplement, personal care and specialty nutrition industries. | Location Winston-Salem | |
Company Nelum Corp. | Activity: Research and Development | Company Description Nelum is a clinical-stage biopharmaceutical company developing patented drugs through an in-license process. Nelum´s focus is in oncology and fibrotic indications. | Location Cary | |
Company NeuroGT Inc. | Activity: Research and Development | Company Description NeuroGT is developing gene therapy products to treat rare neurogenetic diseases. | Location Chapel Hill | |
Company New Hope Biodiagnostics LLC | Activity: Research and Development | Company Description New Hope Biodiagnostics is developing biodiagnostics for cancer. | Location Chapel Hill | |
Company Nicox Ophthalmics | Activity: Research and Development | Company Description Nicox Ophthalmics develops therapeutics from a proprietary nitric-oxide research platform to help maintain vision and improve ocular health. | Location Durham | |
Company NIRvana Sciences Inc. | Activity: Research and Development | Company Description NIRvana Sciences is commercializing red and near-infrared fluorescent dyes for use in diagnostics and imaging applications. | Location Research Triangle Park | |
Company Nova Thin Film Pharmaceuticals LLC | Activity: Research and Development | Company Description Nova Thin Film Pharmaceuticals develops and manufactures dissolving thin film using patented DepoFilm technology to solve drug delivery challenges. | Location Greensboro | |
Company NovaCyte LLC | Activity: Research and Development | Company Description NovaCyte isolates cells from donor corneas to grow replacement corneal tissue on a scaffold as a bioengineered equivalent to the current standard of care. | Location Winston-Salem | |
Company Novonesis BioAg | Activity: Research and Development | Company Description Novonesis BioAg develops microbial-based biofertility, biocontrol and bioyield enhancer products for agriculture. The Morrisville site focuses on fermentation and production technology. | Location Morrisville | |
Company Nufarm Americas Inc. | Activity: Research and Development | Company Description Nufarm manufactures and markets insecticides, fungicides, plant growth regulators and herbicides. This site serves as Nufarm's primary research and development facility in the United States. | Location Morrisville | |
Company NuPulseCV | Activity: Research and Development | Company Description NuPulseCV is developing an implantable cardiovascular left ventricular assist device to treat people suffering from congestive heart failure. | Location Raleigh | |
Company NuRevelation LLC | Activity: Research and Development | Company Description NuRevelation develops drug delivery methods for pharmaceuticals, nutraceuticals and cannabinoids. | Location Durham | |
Company Ocaro Pharmaceuticals | Activity: Research and Development | Company Description Ocaro Pharmaceuticals develops opioid-sparing pain medications. | Location Greensboro | |
Company Oerth Bio LLC | Activity: Research and Development | Company Description Oerth Bio is supporting crop protection, crop health, and healthy food by leveraging PROTAC® protein degrades, which work by harnessing the plant's own natural protein disposal system to degrade and remove unwanted proteins. | Location Durham | |
Company Olfax LLC | Activity: Research and Development | Company Description Olfax Medical is developing nasally administered therapeutics to help patients avoid the harmful and addictive side effects of systemic pharmaceuticals. | Location Asheville | |
Company Om Bharti LLC | Activity: Research and Development | Company Description Om Bharti is developing a machine-learning software product that will integrate and analyze large sets of biological data to provide actionable outputs that expedite research, development, industrialization, and optimization. | Location Wilmington | |
Company On.Target Molecules Biotech Inc. | Activity: Research and Development | Company Description O.TM Biotech is developing anti-cancer monoclonal antibodies using a novel technology platform to accelerate advancements in cancer therapeutics. | Location Wilmington | |
Company OncoTAb Inc. | Activity: Research and Development | Company Description OncoTAb develops a continuum of products from early detection to treatment of epithelial cancers. Current products on the market and under development address unmet needs in the detection and treatment of pancreatic cancer as well as triple negative and metastatic breast cancer. | Location Charlotte | |
Company Oncotect | Activity: Research and Development | Company Description Oncotect is a chemical and biomolecular diagnostic company developing technology for the early detection of cancer in dogs. | Location Raleigh | |
Company Oncurie Inc. | Activity: Research and Development | Company Description Oncurie is developing a cure for metastatic cancer through the use of novel molecular radionuclide technology. | Location Raleigh | |
Company OnSite Remediation LLC | Activity: Research and Development | Company Description OnSite Remediation develops and uses naturally-occurring microbes, mechanical separators, coalescing units and filtration systems for the removal of contaminants from water and soil. | Location Cary | |
Company Optera LLC | Activity: Research and Development | Company Description Optera is developing a technology to improve honey bee Varroa-mite resistance. | Location Greensboro | |
Company Opus Genetics Inc. | Activity: Research and Development | Company Description Opus Genetics is a clinical-stage gene therapy company developing treatments for inherited retinal diseases. | Location Research Triangle Park | |
Company Osmotica Pharmaceutical Corp. | Activity: Research and Development | Company Description Osmotica Pharmaceutical specializes in drug-delivery technologies and neurology-based therapies, including a treatment for Parkinson's disease. | Location Wilmington | |
Company OsteoCure Therapeutics Inc. | Activity: Research and Development | Company Description OsteoCure Therapeutics develops novel treatments to accelerate and promote bone fracture healing and prevent nonunions. | Location Durham | |
Company Outbreaks Inc. | Activity: Research and Development | Company Description Outbreaks produces over-the-counter homeopathic solutions for cold sores and other ailments that cause uncomfortable outbreaks. | Location Cary | |
Company Pairwise | Activity: Research and Development | Company Description Pairwise develops new varieties of crops by developing genome editing tools, leveraging plants' natural genetic diversity, and creating partnerships and collaborations with agriculture companies. | Location Durham | |
Company Panafina LLC | Activity: Research and Development | Company Description Panafina is developing a product for acute severe pancreatitis. | Location Morrisville | |
Company Parion Sciences Inc. | Activity: Research and Development | Company Description Parion Sciences develops therapies to treat defects of the innate mucosal defense system in respiratory diseases. | Location Durham | |
Company Path BioAnalytics Inc. | Activity: Research and Development | Company Description Path BioAnalytics (PBA) is a precision medicine company dedicated to the advancement of next-generation of treatments for individuals living with respiratory disease. | Location Durham | |
Company Pathalys Pharma Inc. | Activity: Research and Development | Company Description Pathalys Pharma develops therapeutics that address unmet needs in the management of end stage kidney disesase (ESKD). | Location Raleigh | |
Company Pathfinder Pharmaceuticals Inc. | Activity: Research and Development | Company Description Pathfinder Pharmaceuticals specializes in early stage drug discovery with a focus on cancer therapy. | Location Durham | |
Company Perfusio | Activity: Research and Development | Company Description Perfusio is developing, manufacturing and marketing platform technology for non-invasive surgical imaging that enables the providers to see real-time images of blood flow distribution and tissue perfusion without patient contact or injection of dye. | Location Greenville | |
Company Pertinent Eco-Solutions | Activity: Research and Development | Company Description Pertinent Eco Solutions has developed pest control products consisting of plant-derived active ingredients to replace traditional chemical pesticides. | Location Research Triangle Park | |
Company Pfizer (Morrisville) | Activity: Research and Development | Company Description Pfizer (Morrisville) develops robust, scalable and compliant processes for manufacture of biologics (gene therapies, multispecific antibodies, and complex proteins) and conducts analytical testing for drug substance manufacture. | Location Morrisville | |
Company Pfizer Inc. (Durham) | Activity: Research and Development | Company Description Pfizer develops gene therapies to treat rare genetic central nervous system (CNS) and neuromuscular diseases. Pfizer's BioTherapeutics Pharmaceutical Sciences site in Durham houses clinical manufacturing space and analytical research development laboratories. | Location Durham | |
Company Pharmgate Animal Health LLC | Activity: Research and Development | Company Description Pharmgate Animal Health develops and markets medicines and vaccines for the control of disease in livestock and poultry in North America. | Location Wilmington | |
Company PHAXTEC Inc. | Activity: Research and Development | Company Description PHAXTEC is an advanced materials start-up commercializing and marketing novel natural materials based on PolyHydroxyAlkanoates (PHA) that are recyclable, marine biodegradable and home & industrially compostable. | Location Wake Forest | |
Company Phenom Pharmaceuticals LLC | Activity: Research and Development | Company Description Phenom Pharmaceuticals develops preventatives and therapeutics. | Location Charlotte | |
Company PhosphoGam Inc. | Activity: Research and Development | Company Description PhosphoGam is developing allogeneic cell immunotherapies using gamma/delta T-cells to treat a variety of cancers. | Location Durham | |
Company PhotoCide Protection Inc. | Activity: Research and Development | Company Description PhotoCide Protection develops self-disinfecting materials based on technology combining engineered cellulose with photosensitizers which emit singlet oxygen, an environmentally-friendly biocidal agent which destroys pathogens on surfaces. | Location Apex |